Charles River Massachusetts will open in January 2016.
This 450,000 square foot facility increases capacity for PK services, non-GLP toxicology, GLP toxicology and small molecule bioanalysis, with plans to add services each year. Conveniently located just outside of Boston in Shrewsbury, the facility provides Cambridge-area clients direct access to their studies.
“As a premier CRO, Charles River is committed to providing you with the tools and information you need to accelerate your development programs. You can trust our industry-leading science, regulatory expertise, and superior customer service to support you, every step of the way. We combine scientific excellence and cutting edge technologies to advance your drug discovery. Our skilled scientists and responsive study directors act as an extension of your team, providing timely, thoughtful guidance and services that are aligned with your study goals throughout your project.”
- Article: Charles River to reopen Shrewsbury research facility
“Charles River Laboratories International Inc. will reopen its sprawling complex on South Street next year, nearly six years after shrinking demand had prompted the company to shutter the building. The Wilmington-based business is spending about $1.5 million to prepare and renovate about half of the facility listed in town records as covering about 412,000 square feet of space. Charles River plans to open during the first three months of 2016 with an undisclosed number of workers. Some likely will be transferred from other Charles River locations.
“Increasing demand from our clients for early-stage drug research services makes this the ideal time to reopen the site,” Amy Cianciaruso, a spokeswoman for the company, said in an email.Charles River is a contract research organization that performs laboratory studies, including animal testing, for drugmakers. The company employs about 8,500 people worldwide. It posted about $1.3 billion in revenue and about $127 million in profit during 2014.In Shrewsbury, the company expects to offer early-stage drug discovery services and bioanalysis, Ms. Cianciaruso said. Charles River expects to expand offerings based on client demands, she said. Charles River’s decision reflects a resurgence in the biotechnology community in Boston, said Michael Jirousek, a consultant who has worked at large pharmaceutical companies and founded Catabasis Pharmaceuticals Inc. Companies that have opted to stay lean hire outsiders to perform work, but still need to participate in the research, he said.” Full article
Lastly, take a look at some FAQs:
- How far is CR Massachusetts from the Boston airport? The facility is located 40 miles from the Boston-Logan International Airport.
- Will you be AAALAC accredited? Yes.
- Can I take a tour of the facility? Yes. If you would like to take a tour please contact us at firstname.lastname@example.org. We would be happy to host you.
- Can I lease space at CR Massachusetts? The site has a large vivarium as well as office and meeting space. If you are interested in renting any of these facilities, please contact us at email@example.com.
- Will you conduct in vivo studies at both the Wilmington, Massachusetts and CR Massachusetts sites? No. As of mid-January 2016, all new studies will be initiated at CR Massachusetts. Projects already in progress at that time will continue in Wilmington until they are completed.
- Are the services listed above all inclusive of everything that will ever be offered? No. We will be expanding each year based on client interest and demand. Have a need for a specific service? Let us know.
- Are you hiring? Yes. View our open positions.